Amarin to Present at the 2023 Cantor Global Healthcare Conference
12 9월 2023 - 9:00PM
Amarin Corporation plc (NASDAQ: AMRN) today announced that Patrick
Holt, Amarin’s president and chief executive officer, is scheduled
to participate via fireside chat at the 2023 Cantor Global
Healthcare Conference.
2023 Cantor Global Healthcare Conference (Sept 26 – 28th, 2023;
NYC)
Date/Time: Tuesday, Sep 26 at 9:55-10:25 AM ET in
Track 1
Webcast: https://wsw.com/webcast/cantor19/amrn/2092398
The conference audio will be webcast live and archived on the
Company’s website in the Investor Relations section under Events
and Presentations.
About Amarin
Amarin is an innovative pharmaceutical company
leading a new paradigm in cardiovascular disease management. From
our foundation in scientific research to our focus on clinical
trials, and now our commercial expansion, we are evolving and
growing rapidly. Amarin has offices in Bridgewater, New Jersey in
the United States, Dublin in Ireland, Zug in Switzerland, and other
countries in Europe as well as commercial partners and suppliers
around the world. We are committed to increasing the scientific
understanding of the cardiovascular risk that persists beyond
traditional therapies and advancing the treatment of that
risk.
Availability of Other Information About
Amarin
Amarin communicates with its investors and the public using the
company website (www.amarincorp.com) and the investor relations
website (amarincorp.gcs-web.com), including but not limited to
investor presentations and FAQs, Securities and Exchange Commission
filings, press releases, public conference calls and webcasts. The
information that Amarin posts on these channels and websites could
be deemed to be material information. As a result, Amarin
encourages investors, the media and others interested in Amarin to
review the information that is posted on these channels, including
the investor relations website, on a regular basis. This list of
channels may be updated from time to time on Amarin’s investor
relations website and may include social media channels. The
contents of Amarin’s website or these channels, or any other
website that may be accessed from its website or these channels,
shall not be deemed incorporated by reference in any filing under
the Securities Act of 1933.
Amarin Contact Information
Investor Inquiries: Jordan Zwick Amarin Corporation
plc IR@amarincorp.com (investor
inquiries)
Media Inquiries:Mark Marmur Amarin Corporation
plc PR@amarincorp.com (media
inquiries)
Amarin (NASDAQ:AMRN)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Amarin (NASDAQ:AMRN)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024